Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up

SourceEndpoints News
Date Published03/10/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Thermo Fisher Scientific Inc.
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):500
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2022
Domestically, the work will be done:In-house
Capital investment ($):200
If relevant, work nearshored to:-
Product(s) reshoredcovid-19 therapies and vaccines
What domestic positive factors made reshoring more attractive?, covid-19, essential product
Find Reshoring Articles